Publication | Closed Access

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells

Breast OncologySignaling PathwayGrowth-inhibitory EffectsReceptor Tyrosine KinaseHormonal ReceptorBreast Cancer CellsEstrogen ReceptorBreast CancerCell BiologyMedicineRadiation OncologyCell SignalingEndocrine-related Cancer